These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31438464)
1. High Positive Correlations between Drak Alsibai K; Vacher S; Meseure D; Nicolas A; Lae M; Schnitzler A; Chemlali W; Cros J; Longchampt E; Cacheux W; Pignot G; Callens C; Pasmant E; Allory Y; Bieche I Noncoding RNA; 2019 Aug; 5(3):. PubMed ID: 31438464 [TBL] [Abstract][Full Text] [Related]
2. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Pasmant E; Laurendeau I; Héron D; Vidaud M; Vidaud D; Bièche I Cancer Res; 2007 Apr; 67(8):3963-9. PubMed ID: 17440112 [TBL] [Abstract][Full Text] [Related]
4. Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas. Simon M; Köster G; Menon AG; Schramm J Acta Neuropathol; 1999 Nov; 98(5):444-52. PubMed ID: 10541865 [TBL] [Abstract][Full Text] [Related]
5. Li Z; Qiao J; Ma W; Zhou J; Gu L; Deng D; Zhang B Front Cell Dev Biol; 2022; 10():993525. PubMed ID: 36176277 [No Abstract] [Full Text] [Related]
6. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
7. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value. Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007 [TBL] [Abstract][Full Text] [Related]
8. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910 [TBL] [Abstract][Full Text] [Related]
9. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Kotake Y; Nakagawa T; Kitagawa K; Suzuki S; Liu N; Kitagawa M; Xiong Y Oncogene; 2011 Apr; 30(16):1956-62. PubMed ID: 21151178 [TBL] [Abstract][Full Text] [Related]
11. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. Pasmant E; Sabbagh A; Vidaud M; Bièche I FASEB J; 2011 Feb; 25(2):444-8. PubMed ID: 20956613 [TBL] [Abstract][Full Text] [Related]
12. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation. Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918 [TBL] [Abstract][Full Text] [Related]
13. ANRIL inhibits p15(INK4b) through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma. Chen D; Zhang Z; Mao C; Zhou Y; Yu L; Yin Y; Wu S; Mou X; Zhu Y Cell Immunol; 2014; 289(1-2):91-6. PubMed ID: 24747824 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors. Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917 [TBL] [Abstract][Full Text] [Related]
15. Circular Muniz L; Lazorthes S; Delmas M; Ouvrard J; Aguirrebengoa M; Trouche D; Nicolas E RNA Biol; 2021 Mar; 18(3):404-420. PubMed ID: 32862732 [TBL] [Abstract][Full Text] [Related]
16. Alterations of p14 López F; Sampedro T; Llorente JL; Hermsen M; Álvarez-Marcos C Pathol Oncol Res; 2017 Jan; 23(1):63-71. PubMed ID: 27377733 [TBL] [Abstract][Full Text] [Related]
17. Islet biology, the CDKN2A/B locus and type 2 diabetes risk. Kong Y; Sharma RB; Nwosu BU; Alonso LC Diabetologia; 2016 Aug; 59(8):1579-93. PubMed ID: 27155872 [TBL] [Abstract][Full Text] [Related]
18. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276 [TBL] [Abstract][Full Text] [Related]
19. CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours. Rousseau E; Ruchoux MM; Scaravilli F; Chapon F; Vinchon M; De Smet C; Godfraind C; Vikkula M Neuropathol Appl Neurobiol; 2003 Dec; 29(6):574-83. PubMed ID: 14636164 [TBL] [Abstract][Full Text] [Related]
20. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. Burd CE; Jeck WR; Liu Y; Sanoff HK; Wang Z; Sharpless NE PLoS Genet; 2010 Dec; 6(12):e1001233. PubMed ID: 21151960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]